Journal article
The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound
Nadia Warner, Stephen Locarnini
Hepatology | WILEY-BLACKWELL | Published : 2008
DOI: 10.1002/hep.22295
Grants
Awarded by NCRR NIH HHS
Awarded by NIAID NIH HHS